Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Atorvastatin treatment ameliorates cardiac function and remodeling induced by isoproterenol attack through mitigation of ferroptosis
Ning Dong, Xinquan Yang, Ti Wang, et al.
Biochemical and Biophysical Research Communications (2021) Vol. 574, pp. 39-47
Closed Access | Times Cited: 41

Showing 1-25 of 41 citing articles:

The molecular and metabolic landscape of iron and ferroptosis in cardiovascular disease
Xuexian Fang, Hossein Ardehali, Junxia Min, et al.
Nature Reviews Cardiology (2022) Vol. 20, Iss. 1, pp. 7-23
Open Access | Times Cited: 626
Glutathione system enhancement for cardiac protection: pharmacological options against oxidative stress and ferroptosis
Mingyue Tan, Yunfei Yin, Xiao Ma, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 2
Open Access | Times Cited: 94
Ferroptosis mechanisms and regulations in cardiovascular diseases in the past, present, and future
Wenxi Fang, Saiyang Xie, Wei Deng
Cell Biology and Toxicology (2024) Vol. 40, Iss. 1
Open Access | Times Cited: 22
Ferroptosis in heart failure
Xinquan Yang, Nicholas K. Kawasaki, Junxia Min, et al.
Journal of Molecular and Cellular Cardiology (2022) Vol. 173, pp. 141-153
Open Access | Times Cited: 65
Resveratrol Attenuate Myocardial Injury by Inhibiting Ferroptosis Via Inducing KAT5/GPX4 in Myocardial Infarction
Jing Liu, Mingming Zhang, Chaoshi Qin, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 53
Canagliflozin mitigates ferroptosis and ameliorates heart failure in rats with preserved ejection fraction
Sai Ma, Lili He, Guorui Zhang, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2022) Vol. 395, Iss. 8, pp. 945-962
Open Access | Times Cited: 51
Ferroptosis, a new pathogenetic mechanism in cardiometabolic diseases and cancer: Is there a role for statin therapy?
Amirhossein Sahebkar, Zahra Foroutan, Niki Katsiki, et al.
Metabolism (2023) Vol. 146, pp. 155659-155659
Closed Access | Times Cited: 32
Oxidative Stress and MicroRNAs in Endothelial Cells under Metabolic Disorders
Morgan Minjares, Wendy Wu, Jie‐Mei Wang
Cells (2023) Vol. 12, Iss. 9, pp. 1341-1341
Open Access | Times Cited: 26
Mitochondrial GPX4 acetylation is involved in cadmium-induced renal cell ferroptosis
Yue‐Yue Guo, Nannan Liang, Xiaoyi Zhang, et al.
Redox Biology (2024) Vol. 73, pp. 103179-103179
Open Access | Times Cited: 14
Ferroptosis, a Regulated Form of Cell Death, as a Target for the Development of Novel Drugs Preventing Ischemia/Reperfusion of Cardiac Injury, Cardiomyopathy and Stress-Induced Cardiac Injury
V. V. Ryabov, Л. Н. Маслов, Evgeniy V. Vyshlov, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 2, pp. 897-897
Open Access | Times Cited: 11
Atorvastatin ameliorates diabetic nephropathy through inhibiting oxidative stress and ferroptosis signaling.
Yaoxia Zhang, Yuanyuan Qu, Ruiping Cai, et al.
European Journal of Pharmacology (2024) Vol. 976, pp. 176699-176699
Closed Access | Times Cited: 9
Ferroptosis in cardiac hypertrophy and heart failure
K. Zhang, Xin-Miao Tian, Wei Li, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 168, pp. 115765-115765
Open Access | Times Cited: 18
Epigenetic regulation of diverse regulated cell death modalities in cardiovascular disease: Insights into necroptosis, pyroptosis, ferroptosis, and cuproptosis
Cong Chen, Jie Wang, Shan Zhang, et al.
Redox Biology (2024) Vol. 76, pp. 103321-103321
Open Access | Times Cited: 8
Inhibition of ferroptosis reverses heart failure with preserved ejection fraction in mice
Yixiao Xiong, Xin Liu, Ling Jiang, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 7
Pharmacological approaches for targeting lysosomes to induce ferroptotic cell death in cancer
Feng Ji, Zixuan Wang, Jin-Lian Bin, et al.
Cancer Letters (2024) Vol. 587, pp. 216728-216728
Closed Access | Times Cited: 6
Atorvastatin attenuates ferroptosis-dependent myocardial injury and inflammation following coronary microembolization via the Hif1a/Ptgs2 pathway
Tao Liu, Jin Shu, Yangchun Liu, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 20
The effects of statins on mitochondria – the current state of knowledge
Małgorzata Belczyk, Małgorzata Knapik-Czajka, Anna Gawędzka, et al.
Farmacja Polska (2025) Vol. 80, Iss. 8, pp. 579-587
Open Access
Atorvastatin attenuates the expression of damage-associated molecular patterns and inflammatory cytokines in patients with psoriasis
Kalliopi Armyra, Amin M. Ektesabi, James N. Tsoporis, et al.
Pharmacological Reports (2025)
Closed Access
Exploring the potential mechanism of atorvastatin in regulating ferroptosis as a treatment for heart failure based on network pharmacology
Yuting Bai, Yiqi Wang, Yanmin Liu, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Closed Access
Natural products and ferroptosis: A novel approach for heart failure management
Zeyu Zhang, Zhihua Yang, Shuai Wang, et al.
Phytomedicine (2025) Vol. 142, pp. 156783-156783
Closed Access
Ferroptosis: a new strategy for cardiovascular disease
Yuyuan Wang, Junduo Wu
Frontiers in Cardiovascular Medicine (2023) Vol. 10
Open Access | Times Cited: 10
A panoramic view of ferroptosis in cardiovascular disease
Xihao Cheng, Chao Yu, Xinquan Yang, et al.
Kidney Diseases (2023) Vol. 9, Iss. 3, pp. 173-186
Open Access | Times Cited: 9
Atorvastatin Inhibits Ferroptosis of H9C2 Cells by regulatingSMAD7/Hepcidin Expression to Improve Ischemia-Reperfusion Injury
You Peng, Bin Liao, Yan Zhou, et al.
Cardiology Research and Practice (2022) Vol. 2022, pp. 1-12
Open Access | Times Cited: 15
Outlook of Ferroptosis-Targeted Lipid Peroxidation in Cardiovascular Disease
Ze-Fan Wu, Xi-Yan Liu, Nian-Hua Deng, et al.
Current Medicinal Chemistry (2022) Vol. 30, Iss. 31, pp. 3550-3561
Closed Access | Times Cited: 14
Research advances on molecular mechanism and natural product therapy of iron metabolism in heart failure
Tianqing Zhang, Li Luo, Qi He, et al.
European journal of medical research (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top